Company: AMTX
Filing Date: 2025-02-12
Form Type: 424B5
Source: 0001437749-25-003485
Chunk: 19

Company: AEMETIS, INC
Filing Date: 2025-02-12
Form: 424B5
Chunk 19
---
 the first business day following the date on which any sales are made, or on some other date that is agreed upon by us and the distribution agent in connection with a particular transaction, in return for payment of the net proceeds to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.

In connection with the sale of the common stock on our behalf, the distribution agent will be deemed to be an underwriter within the meaning of the Securities Act, and the compensation of the distribution agent will be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to the distribution agent against certain civil liabilities, including liabilities under the Securities Act.

The offering pursuant to the sales agreement will terminate upon the earlier of (1) the issuance and sale of all shares or our common stock subject to the sales agreement; and (2) the termination of the sales agreement as permitted therein.

The distribution agent and its affiliates may in the future provide various investment banking and other financial services for us and our affiliates, for which services they may in the future receive customary fees. To the extent required by Regulation M, the distribution agent will not engage in any market making activities involving our common stock while the offering is ongoing under this prospectus supplement. This summary of the material provisions of the sales agreement does not purport to be a complete statement of its terms and conditions. A copy of the sales agreement is filed with the SEC and is incorporated by reference into the registration statement of which this prospectus supplement is a part.

Our common stock is listed on the Nasdaq Global Market under the symbol “AMTX.” On February 5, 2025, the last reported sale price of our common stock on the Nasdaq Global Market was $2.11 per share.

<div align='center'>S-15

LEGAL MATTERS</div>

The validity of the shares of common stock offered hereby and certain other matters have been passed upon for us by Allen Overy Shearman Sterling US LLP. Ellenoff Grossman & Schole LLP is counsel for the distribution agent in connection with this offering.

<div align='center'>EXPERTS</div>

The consolidated financial statements of Aemetis, Inc. as of December 31, 2023 and 2022, and for each of the years in the two-year period ended December 31, 2023, and the effectiveness of internal control over financial reporting as of December 31, 2023, incorporated in this Prospectus by reference from